Patrick Beyrer

How has US-China biotechnology competition evolved and what are the stakes? Excited to share my latest with @AsiaPolicy tracking new developments in this emerging frontier of US-China tech rivalry. /1 shorturl.at/kwMQ1

What are the core dilemmas shaping China’s trajectory in 2026? Our new @AsiaPolicy report shows a China that is dynamic yet constrained—balancing control with vitality, security with development, ambition with caution, and resilience with fragility What Will Xi Jinping's Priorities Be in 2026? —Myself & Lobsang Tsering How Will the Next Generation of Chinese Leaders Reconcile Effective Governance and Party Loyalty? — @guoguang_wu Can China Reconcile Private-Sector Vitality with State-Led Innovation? — @wstv_lizzi Can Beijing Truly Pivot Toward a Consumption-Led Economy? — @choyleva Can the United States and China Find a New Equilibrium on Trade and Technology? —Brendan Kelly & @MichaelHirson How Does Beijing Read U.S. Power—and How Will It Shape China's Foreign Policy Posture? — @sungminchohi & @PhLeCorre Will Beijing Recalibrate Its Approach to Taiwan? — @LyleJMorris Can Beijing Contain Public Frustration over High Inequality, Youth Unemployment, and Economic Strain? — @barclaybram Can Beijing Preserve Growth and Stability amid Rapid Demographic Change? — @DrEmmaZang Can China Sustain Its Rise as a Global Pharmaceutical Innovator? — @patbeyrer & Chang Liu Will China Assume Greater Climate Leadership in Light of U.S. Retreat? — @LiShuo_GP Can China Turn Its Clean Energy Dominance into Green Soft Power? — @Kate_K_Logan

Where does the US-China trade war go from here? On tariffs, US will continue with 232s and prep new 301s; I think existing 301 can cover China. But tariffs could be on the back burner in the near term. New focus for US-China is export controls. 1/

1/ Secretary Lutnick’s message is important for setting expectations. Chinese President Jiang Zemin sent a telegram of condolence to George W Bush on September 11, 2001, but beyond that, it is exceedingly rare for a PRC leader to initiate outreach to a US president. (🧵)

A congressional commission warned that China is making big strides in biotechnology and the U.S. must invest more in research and take other steps to protect its national security on.wsj.com/3GaTPqw

Here comes the booming Chinese biotech sector trib.al/pWKEjhH

@AsiaSociety And with today’s news from China, understanding great power biotech rivalry between Washington and Beijing is even more critical. For more, see my @AsiaPolicy piece last spring detailing the state of US-China biotech competition: shorturl.at/jl9cx

@AsiaSociety Progress on joint cancer trials can help overcome structural challenges within US-China tensions while delivering on a global public good for humanity. Coordinating a practical bilateral framework, despite legitimate obstacles, holds the potential to save millions of lives. 14/

Pleased to publish a new @AsiaSociety report on #WorldCancerDay. Drawing on the work of scientists, policymakers, and more, this report identifies the challenges and opportunities within US-China scientific ties to change cancer care as we know it. 🧵 shorturl.at/Af4oH